The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy
Open accessAbstract
BACKGROUND: The prognosis of IgA nephropathy (IgAN) is variable and about 10-20% of patients progress to end-stage renal disease (ESRD) in 10 years. Hypertension, proteinuria and renal insufficiency at the time of diagnosis are risk factors associated with poor prognosis. Lipid abnormalities may have a role in the progression of glomerulonephritides, and glomerulosclerosis and atherosclerosis may have similar pathophysiological mechanisms. We therefore evaluated factors associated with cardiovascular diseases, especially hypercholesterolaemia, hypertriglyceridaemia, and hyperuricaemia, as predictors of the progression of IgAN. METHODS: A total of 223 patients with IgAN (141 men, 82 women; median age 41 years, range 8-78 years) were studied. The following parameters were recorded at the time of renal biopsy: presence of hypertension or diabetes, smoking habits, body mass index (BMI), serum creatinine, total and HDL-cholesterol, triglycerides, and urate and 24-h urinary protein excretion. The patients were followed up for 0.2-17 years (median 10 years) with respect to progression of renal disease defined as elevation of serum creatinine above 125 micromol/l in men or 105 micromol/l in women, and over 20% elevation from baseline. RESULTS: Forty-one patients (18%) showed progression. Hypertriglyceridaemia and hyperuricaemia were significantly more common at the time of renal biopsy in patients with progressive than in those with stable disease. In patients with normal renal function at the time of diagnosis initial hypertriglyceridaemia, hyperuricaemia, hypertension and proteinuria were independent risk factors for progression of IgAN in the Cox regression hazard model. CONCLUSIONS: Our results show that hypertriglyceridaemia and hyperuricaemia at the time of diagnosis are important, previously underestimated predictors of poor outcome in IgAN, although causality between these factors and progression cannot be inferred from the present study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Smithson, M. (2000) · SAGE Publications Ltd eBooks · doi:10.4135/9781446218525 · Cited by 1,871
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE
Moorhead, J. F., El-Nahas, M., Chan, M. K., & Varghese, Z. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91513-6 · Cited by 1,070
Facchini, F. (1991) · JAMA · doi:10.1001/jama.1991.03470210076036 · Cited by 885
The Commonest Glomerulonephritis in the World: IgA Nephropathy
(1987) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068143 · Cited by 870
Morris, J. A., & Gardner, M. J. (1988) · BMJ · doi:10.1136/bmj.296.6632.1313 · Cited by 764
Jeppesen, J. Ø., Hein, H. O., Suadicani, P., & Gyntelberg, F. (1998) · Circulation · doi:10.1161/01.cir.97.11.1029 · Cited by 676
Lipoproteins and atherogenesis. Current concepts
Steinberg, D. (1990) · JAMA · doi:10.1001/jama.264.23.3047 · Cited by 581
Hyperuricemia in Primary and Renal Hypertension
Cannon, P. J., Stason, W. B., Demartini, F. E., Sommers, S. C., & Laragh, J. H. (1966) · New England Journal of Medicine · doi:10.1056/nejm196609012750902 · Cited by 505
Lehto, S., Niskanen, L., Rönnemaa, T., & Laakso, M. (1998) · Stroke · doi:10.1161/01.str.29.3.635 · Cited by 411
Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats
Kasiske, B. L., O'donnell, M. P., Cleary, M. P., & Keane, W. F. (1988) · Kidney International · doi:10.1038/ki.1988.51 · Cited by 409
HYPERURICEMIA AS A RISK FACTOR OF CORONARY HEART DISEASE: THE FRAMINGHAM STUDY
BRAND, F. N., MCGEE, D. L., KANNEL, W. B., STOKES, J., & CASTELLI, W. P. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113972 · Cited by 390
Hypertriglyceridemia: A Metabolic Consequence of Chronic Renal Failure
Bagdade, J. D., Porte, D., & Bierman, E. L. (1968) · New England Journal of Medicine · doi:10.1056/nejm196807252790403 · Cited by 382
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease
Fliser, D., Pacini, G., Engelleiter, R., Kautzky-Willer, A., Prager, R., Franek, E., & Ritz, E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00898.x · Cited by 359
Lipoprotein Metabolism and Renal Failure
Attman, P.-O., Samuelsson, O., & Alaupovic, P. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80030-8 · Cited by 355
Gout and coronary heart disease: The framingham study
Abbott, R. D., Brand, F. N., Kannel, W. B., & Castelli, W. P. (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90127-8 · Cited by 355
Alamartine, E., Sabatier, J.-C., Guerin, C., Berliet, J.-M., & Berthoux, F. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80284-8 · Cited by 283
Johnson, R. J., Kivlighn, S. D., Kim, Y.-G., Suga, S., & Fogo, A. B. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70295-7 · Cited by 267
Elevated serum uric acid ? a facet of hyperinsulinaemia
Modan, M., Halkin, H., Karasik, A., & Lusky, A. (1987) · Diabetologia · doi:10.1007/bf00296994 · Cited by 263
Samuelsson, O., Mulec, H., Knight-Gibson, C., Attman, P., Kron, B., Larrson, R., Weiss, L., Wedel, H., & Alaupovic, P. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.9.1908 · Cited by 234
Effects of hypertension and dyslipidemia on the decline in renal function
Mänttäri, M., Tiula, E., Alikoski, T., & Manninen, V. (1995) · Hypertension · doi:10.1161/01.hyp.26.4.670 · Cited by 229
Keane, W. F. (1994) · Kidney International · doi:10.1038/ki.1994.349 · Cited by 209
Lipoproteins and Atherosclerosis
Gofman, J. W., Lindgren, F. T., Jones, H. B., Lyon, T. P., & Strisower, B. (1951) · Journal of Gerontology · doi:10.1093/geronj/6.2.105 · Cited by 207
Lipids and Progressive Glomerulosclerosis
Keane, W. F., Kasiske, B. L., & O’Donnell, M. P. (1988) · American Journal of Nephrology · doi:10.1159/000167599 · Cited by 202
Cholesterol-lowering therapy may retard the progression of diabetic nephropathy
Lam, K. S. L., Cheng, I. K. P., Janus, E. D., & Pang, R. W. C. (1995) · Diabetologia · doi:10.1007/bf00400731 · Cited by 194
Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis.
Diamond, J. R. (1991) · PubMed · Cited by 184
The insulin resistance syndrome and postprandial lipid intolerance in smokers
Eliasson, B., Mero, N., Taskinen, M., & Smith, U. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06028-5 · Cited by 174
Harris, K. P. G., Purkerson, M. L., Yates, J., & Klahr, S. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80587-7 · Cited by 146
The kidney: an unwilling accomplice in syndrome X
Reaven, G. M. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90106-2 · Cited by 145
Krolewski, A. S., Warram, J. H., & Christlieb, A. R. (1994) · PubMed · Cited by 137
Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation
Diamond, J. R., & Karnovsky, M. J. (1987) · Kidney International · doi:10.1038/ki.1987.259 · Cited by 137
Uric acid: a risk factor for coronary heart disease?
Persky, V., Dyer, A. R., Idris-Soven, E., et al. (1979) · Circulation · doi:10.1161/01.cir.59.5.969 · Cited by 131
Cholesterol: A Renal Risk Factor in Diabetic Nephropathy
Mulec, H., Johnsen, S. A., Wiklund, O., & Björck, S. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70186-5 · Cited by 121
Triglycerides are more important in atherosclerosis than epidemiology has suggested
Durrington, P. N. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00219-6 · Cited by 83
Dietary induced glomerulosclerosis in the guinea pig.
French, S. W., Yamanaka, W., & Ostwald, R. (1967) · PubMed · Cited by 83
Apolipoprotein-B-Containing Lipoproteins and the Progression of Renal Insufficiency
Samuelsson, O. G., Aurell, M., Knight‐Gibson, C., Alaupovic, P., & Attman, P. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000187210 · Cited by 82
Kasiske, B. L., O’Donnell, M. P., Cowardin, W., & Keane, W. F. (1990) · Hypertension · doi:10.1161/01.hyp.15.5.443 · Cited by 67
Saito, T., Sato, H., Oikawa, S., Kudo, K., Kurihara, I., Nakayama, K., Abe, K., Yoshinaga, K., & Sakaguchi, H. (1993) · American Journal of Nephrology · doi:10.1159/000168591 · Cited by 57
Gjone., E. (1981) · PubMed · Cited by 45
Renal involvement follows cardiac enlargement in essential hypertension.
Kobrin, I., Frohlich, E. D., Ventura, H. O., & Messerli, F. H. (1986) · PubMed · Cited by 35
Effect of dietary manipulation on the lipid abnormalities in patients with chronic renal failure.
Maschio, G., Oldrizzi, L., Rugiu, C., Biase, V. D., & Loschiavo, C. (1991) · PubMed · Cited by 20
Cited by
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D.-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,361
A Role for Uric Acid in the Progression of Renal Disease
Kang, D.-H., Nakagawa, T., Feng, L., Watanabe, S., Han, L., Mazzali, M., Truong, L., Harris, R., & Johnson, R. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034910.58454.fd · Cited by 1,304
Siu, Y.-P., Leung, K.-T., Tong, M. K.-H., & Kwan, T.-H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.006 · Cited by 834
Kanellis, J., Watanabe, S., Li, J. H., Kang, D. H., Li, P., Nakagawa, T., Wamsley, A., Sheikh-Hamad, D., Lan, H. Y., Feng, L., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000072820.07472.3b · Cited by 786
Uric acid and chronic kidney disease: which is chasing which?
Johnson, R. J., Nakagawa, T., Jalal, D., Sanchez-Lozada, L. G., Kang, D.-H., & Ritz, E. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft029 · Cited by 654
Metadata
- Authors
- Syrjänen, J., Mustonen, J., & Pasternack, A.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-01-01
- Volume
- 15
- Issue
- 1
- Pages
- 34-42
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2120330318
- Cited by
- 257
- References
- 44
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.